- ►diabetesjournals.org M Ader, SP Kim, KJ Catalano, V Ionut, K Hucking, JM … - Diabetes, 2005 - Am Diabetes Assoc Atypical antipsychotics have been linked to weight gain, hyperglycemia, and diabetes. We examined
the effects of atypical antipsychotics olanzapine (OLZ) and risperidone (RIS) versus placebo on
adiposity, insulin sensitivity (S I ... Cited by 64 - Related articles - All 7 versions
RN Bergman, M Ader - The Journal of clinical psychiatry, 2005 - ncbi.nlm.nih.gov OBJECTIVES: Persistent reports have linked atypical antipsychotics with diabetes, yet causative
mechanisms responsible for this linkage are unclear. Goals of this review are to outline the
pathogenesis of nonimmune diabetes ... Cited by 82 - Related articles - All 2 versions
- ►endojournals.org M Sowell, N Mukhopadhyay, P Cavazzoni, C … - Journal of Clinical …, 2003 - Endocrine Soc The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated
with olanzapine or risperidone. Subjects were randomly assigned to single-blind therapy with
olanzapine (10 mg/d), risperidone ... Cited by 38 - Related articles - BL Direct - All 6 versions
KL Houseknecht, AS Robertson, W Zavadoski, … - …, 2006 - nature.com Although it is generally accepted that atypical antipsychotics differ in their risk for diabetic
side effects, the underlying pharmacological mechanisms are unknown. Studies on the mechanisms of
antipsychotic-induced hyperglycemia ... Cited by 37 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org DE Johnson, H Yamazaki, KM Ward, AW Schmidt, WS … - Diabetes, 2005 - Am Diabetes Assoc Treatment with the atypical antipsychotics olanzapine and clozapine has been associated with an
increased risk for deterioration of glucose homeostasis, leading to hyperglycemia, ketoacidosis, and
diabetes, in some cases independent ... Cited by 31 - Related articles - All 6 versions
- ►miami.edu [PDF] DC Henderson, E Cagliero, PM Copeland, CP … - Archives of general …, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web standards. Find out
more about why this message is appearing and what you can do to make your experience on this site
better. ... Background While the ... Cited by 160 - Related articles - All 8 versions
- ►psychiatryonline.org KA Graham, DO Perkins, LJ Edwards, RC … - American Journal of …, 2005 - Am Psychiatric Assoc OBJECTIVE: Weight gain is a commonly observed adverse effect of atypical antipsychotic medications,
but associated changes in energy balance and body composition are not well defined. The authors
report here the effect of ... Cited by 65 - Related articles - All 4 versions
ZHIJUN ZHANG, ZHIJ YAO, WEN LIU, QUN FANG, … - The British Journal of …, 2004 - RCP Method Abdominal body fat was determined by magnetic resonance imaging in a group of previously
untreated patients with schizophrenia, before and after 10 weeks' antipsychotic drug treatment. Body
mass and blood concentrations of ... Cited by 104 - Related articles - BL Direct - All 4 versions
HS Vestri, L Maianu, DR Moellering, WT … - …, 2006 - nature.com Treatment with second-generation antipsychotics (SGAs) has been associated with weight gain and the
development of diabetes mellitus, although the mechanisms are unknown. We tested the hypothesis that
SGAs exert direct cellular effects ... Cited by 29 - Related articles - BL Direct - All 5 versions
- ►endojournals.org MO Sowell, N Mukhopadhyay, P Cavazzoni, S … - Journal of Clinical …, 2002 - Endocrine Soc Weight increased significantly (P < 0.01) in the olanzapine (2.8 ± 1.7 kg) and risperidone (3.1 ±
2.1 kg) treatment groups. An increase ( 25%) in the insulin response to hyperglycemia and a decrease
( 18%) in the insulin sensitivity ... Cited by 91 - Related articles - BL Direct - All 4 versions
